| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RecQ Helicases | 30 | 2023 | 35 | 9.530 |
Why?
|
| DNA Repair | 15 | 2020 | 188 | 2.700 |
Why?
|
| DNA Helicases | 17 | 2011 | 41 | 2.680 |
Why?
|
| DNA Damage | 14 | 2020 | 352 | 2.130 |
Why?
|
| Flap Endonucleases | 7 | 2015 | 8 | 1.880 |
Why?
|
| DNA Replication | 11 | 2019 | 152 | 1.770 |
Why?
|
| Genomic Instability | 6 | 2022 | 38 | 1.650 |
Why?
|
| Myocytes, Cardiac | 3 | 2023 | 166 | 1.640 |
Why?
|
| Superoxide Dismutase | 3 | 2023 | 155 | 1.590 |
Why?
|
| DNA | 17 | 2022 | 574 | 1.570 |
Why?
|
| Oxidative Stress | 5 | 2023 | 938 | 1.410 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 1502 | 1.390 |
Why?
|
| Exodeoxyribonucleases | 8 | 2014 | 17 | 1.230 |
Why?
|
| DNA-Binding Proteins | 10 | 2019 | 539 | 1.190 |
Why?
|
| Adenosine Triphosphatases | 10 | 2016 | 82 | 1.170 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 628 | 1.080 |
Why?
|
| Molecular Mimicry | 1 | 2023 | 16 | 0.890 |
Why?
|
| Metalloporphyrins | 1 | 2023 | 12 | 0.890 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2023 | 55 | 0.840 |
Why?
|
| Rotenone | 1 | 2022 | 19 | 0.840 |
Why?
|
| Hela Cells | 11 | 2015 | 366 | 0.800 |
Why?
|
| Mutagens | 2 | 2014 | 69 | 0.760 |
Why?
|
| Humans | 48 | 2023 | 37093 | 0.740 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2020 | 27 | 0.740 |
Why?
|
| Mitochondria | 2 | 2023 | 487 | 0.740 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2019 | 35 | 0.730 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 803 | 0.720 |
Why?
|
| Paraproteinemias | 1 | 2019 | 4 | 0.710 |
Why?
|
| Deoxycytidine | 1 | 2019 | 22 | 0.690 |
Why?
|
| Estrogens | 1 | 2021 | 202 | 0.680 |
Why?
|
| Protein Binding | 14 | 2015 | 972 | 0.650 |
Why?
|
| Genome | 2 | 2019 | 125 | 0.640 |
Why?
|
| Neoplasms | 2 | 2020 | 1103 | 0.630 |
Why?
|
| Chromatin | 3 | 2015 | 169 | 0.620 |
Why?
|
| Hemoglobinopathies | 1 | 2017 | 5 | 0.600 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2017 | 5 | 0.600 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 8 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 807 | 0.580 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 11 | 0.580 |
Why?
|
| Hodgkin Disease | 1 | 2016 | 11 | 0.580 |
Why?
|
| Point Mutation | 1 | 2016 | 93 | 0.540 |
Why?
|
| Cell Movement | 4 | 2023 | 571 | 0.530 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 188 | 0.530 |
Why?
|
| Telomere | 3 | 2015 | 56 | 0.530 |
Why?
|
| Hydroquinones | 1 | 2014 | 8 | 0.500 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 2231 | 0.500 |
Why?
|
| Carrier Proteins | 1 | 2016 | 305 | 0.470 |
Why?
|
| DNA Repair Enzymes | 4 | 2008 | 20 | 0.460 |
Why?
|
| Antigens, Nuclear | 1 | 2013 | 6 | 0.450 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 126 | 0.450 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 626 | 0.440 |
Why?
|
| Nucleic Acid Conformation | 5 | 2013 | 146 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 767 | 0.430 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 78 | 0.410 |
Why?
|
| Filariasis | 3 | 2001 | 3 | 0.390 |
Why?
|
| Sister Chromatid Exchange | 2 | 2007 | 5 | 0.390 |
Why?
|
| Wuchereria bancrofti | 3 | 2001 | 3 | 0.380 |
Why?
|
| Estrogen Receptor alpha | 2 | 2022 | 111 | 0.380 |
Why?
|
| Gene Expression Regulation | 3 | 2022 | 1015 | 0.360 |
Why?
|
| India | 3 | 2019 | 88 | 0.360 |
Why?
|
| Animals | 16 | 2023 | 15081 | 0.360 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 515 | 0.340 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 5 | 2011 | 10 | 0.340 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 5 | 2011 | 18 | 0.330 |
Why?
|
| Setaria Nematode | 2 | 1999 | 2 | 0.330 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 461 | 0.320 |
Why?
|
| Endonucleases | 2 | 2019 | 20 | 0.320 |
Why?
|
| Acetylcholinesterase | 2 | 1999 | 55 | 0.320 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2013 | 53 | 0.300 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 433 | 0.300 |
Why?
|
| Chromosomal Instability | 1 | 2006 | 22 | 0.290 |
Why?
|
| Female | 11 | 2023 | 20969 | 0.290 |
Why?
|
| Cell Line | 6 | 2023 | 1354 | 0.280 |
Why?
|
| Radiochemistry | 1 | 2006 | 6 | 0.270 |
Why?
|
| Protein Structure, Tertiary | 7 | 2006 | 408 | 0.270 |
Why?
|
| DNA, Superhelical | 1 | 2006 | 7 | 0.270 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2005 | 43 | 0.270 |
Why?
|
| DNA, Single-Stranded | 5 | 2006 | 37 | 0.270 |
Why?
|
| Adenosine Triphosphate | 4 | 2016 | 196 | 0.270 |
Why?
|
| Cell Proliferation | 5 | 2023 | 1198 | 0.270 |
Why?
|
| Werner Syndrome | 2 | 2005 | 3 | 0.260 |
Why?
|
| Replication Protein A | 4 | 2017 | 8 | 0.260 |
Why?
|
| Recombination, Genetic | 4 | 2006 | 93 | 0.250 |
Why?
|
| Models, Molecular | 1 | 2008 | 808 | 0.240 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 8 | 0.240 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 76 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 251 | 0.240 |
Why?
|
| RNA Interference | 3 | 2014 | 243 | 0.230 |
Why?
|
| Lactate Dehydrogenases | 1 | 2023 | 1 | 0.230 |
Why?
|
| Cardiolipins | 1 | 2023 | 11 | 0.220 |
Why?
|
| Substrate Specificity | 4 | 2008 | 212 | 0.210 |
Why?
|
| Child, Preschool | 2 | 2017 | 1418 | 0.210 |
Why?
|
| Capillary Permeability | 1 | 2022 | 30 | 0.210 |
Why?
|
| Mice, Knockout | 2 | 2020 | 933 | 0.210 |
Why?
|
| Aging | 1 | 2007 | 664 | 0.210 |
Why?
|
| Sequence Alignment | 2 | 2016 | 265 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2023 | 86 | 0.200 |
Why?
|
| Energy Metabolism | 1 | 2023 | 168 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2021 | 4 | 0.200 |
Why?
|
| Conserved Sequence | 2 | 2016 | 119 | 0.200 |
Why?
|
| Autophagy | 1 | 2022 | 116 | 0.190 |
Why?
|
| Fanconi Anemia | 3 | 2011 | 12 | 0.190 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1180 | 0.190 |
Why?
|
| Child | 3 | 2017 | 3131 | 0.190 |
Why?
|
| Middle Aged | 4 | 2019 | 10129 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 53 | 0.180 |
Why?
|
| Base Sequence | 2 | 2016 | 997 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 213 | 0.180 |
Why?
|
| Keratin-19 | 1 | 2019 | 2 | 0.180 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 131 | 0.180 |
Why?
|
| Electrophoresis | 1 | 2019 | 22 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 27 | 0.180 |
Why?
|
| Cell Survival | 1 | 2023 | 864 | 0.170 |
Why?
|
| Kinetics | 4 | 2007 | 708 | 0.170 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 58 | 0.170 |
Why?
|
| Neurons | 1 | 2007 | 1175 | 0.170 |
Why?
|
| Rats | 2 | 2023 | 3483 | 0.170 |
Why?
|
| Oligonucleotides | 2 | 2013 | 49 | 0.170 |
Why?
|
| Mice | 4 | 2023 | 5913 | 0.170 |
Why?
|
| Antigens, Helminth | 1 | 1999 | 34 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 122 | 0.170 |
Why?
|
| Male | 6 | 2019 | 20025 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2016 | 453 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2012 | 366 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 237 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2023 | 1518 | 0.160 |
Why?
|
| Cell Cycle | 4 | 2019 | 326 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2005 | 1039 | 0.160 |
Why?
|
| Adolescent | 3 | 2017 | 5363 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2017 | 681 | 0.150 |
Why?
|
| Catalysis | 4 | 2006 | 179 | 0.150 |
Why?
|
| Apoptosis | 2 | 2023 | 1398 | 0.150 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 431 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2005 | 448 | 0.150 |
Why?
|
| Electrophoresis, Capillary | 1 | 2017 | 20 | 0.150 |
Why?
|
| Prognosis | 2 | 2016 | 739 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 562 | 0.150 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 20 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2017 | 93 | 0.140 |
Why?
|
| Incidence | 1 | 2019 | 922 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 219 | 0.140 |
Why?
|
| Lymph Nodes | 1 | 2016 | 67 | 0.140 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 2379 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 217 | 0.140 |
Why?
|
| Prevalence | 2 | 2017 | 1455 | 0.140 |
Why?
|
| Catalytic Domain | 2 | 2008 | 109 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2008 | 389 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 421 | 0.130 |
Why?
|
| Adult | 4 | 2017 | 11712 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 55 | 0.120 |
Why?
|
| Precipitin Tests | 2 | 2003 | 52 | 0.120 |
Why?
|
| Infant | 1 | 2017 | 1046 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2017 | 2026 | 0.110 |
Why?
|
| Alleles | 2 | 2022 | 321 | 0.110 |
Why?
|
| Endodeoxyribonucleases | 2 | 2003 | 29 | 0.110 |
Why?
|
| Abortion, Legal | 1 | 2013 | 6 | 0.110 |
Why?
|
| Aphidicolin | 1 | 2013 | 3 | 0.110 |
Why?
|
| Lamin Type B | 1 | 2013 | 2 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2004 | 118 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 928 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 173 | 0.110 |
Why?
|
| Blotting, Western | 3 | 2012 | 859 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2012 | 444 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 132 | 0.110 |
Why?
|
| Immunoblotting | 3 | 2013 | 176 | 0.110 |
Why?
|
| Binding Sites | 2 | 2005 | 651 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2004 | 206 | 0.110 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 13 | 0.110 |
Why?
|
| Oxidants | 1 | 2012 | 45 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 441 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 201 | 0.100 |
Why?
|
| Bloom Syndrome | 1 | 2011 | 1 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 190 | 0.100 |
Why?
|
| Aged | 2 | 2019 | 6741 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2011 | 207 | 0.090 |
Why?
|
| Time Factors | 2 | 2005 | 1742 | 0.090 |
Why?
|
| Young Adult | 2 | 2017 | 4268 | 0.090 |
Why?
|
| DNA, Cruciform | 2 | 2006 | 3 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 409 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2013 | 426 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1207 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2006 | 272 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1568 | 0.080 |
Why?
|
| Ethylmaleimide | 1 | 2007 | 9 | 0.070 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2007 | 5 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 18 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 1371 | 0.070 |
Why?
|
| Demecolcine | 1 | 2006 | 1 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2006 | 13 | 0.070 |
Why?
|
| Electroporation | 1 | 2006 | 18 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 53 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 116 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 93 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 59 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 222 | 0.070 |
Why?
|
| Collodion | 1 | 2006 | 3 | 0.070 |
Why?
|
| Micropore Filters | 1 | 2006 | 2 | 0.070 |
Why?
|
| Plasmids | 1 | 2007 | 246 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 92 | 0.070 |
Why?
|
| HCT116 Cells | 2 | 2017 | 35 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 181 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2006 | 99 | 0.070 |
Why?
|
| Acetylation | 1 | 2005 | 98 | 0.070 |
Why?
|
| G-Quadruplexes | 1 | 2005 | 5 | 0.070 |
Why?
|
| Indoles | 1 | 2006 | 158 | 0.060 |
Why?
|
| Ions | 1 | 2005 | 61 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 290 | 0.060 |
Why?
|
| Magnesium | 1 | 2005 | 97 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 59 | 0.060 |
Why?
|
| Hydroxyurea | 1 | 2004 | 34 | 0.060 |
Why?
|
| Amylose | 1 | 2003 | 5 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 57 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2003 | 172 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2023 | 38 | 0.050 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2022 | 6 | 0.050 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2022 | 19 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 16 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2022 | 19 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.050 |
Why?
|
| Brugia pahangi | 1 | 2001 | 1 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 307 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2001 | 23 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 689 | 0.050 |
Why?
|
| Mutation | 3 | 2013 | 1095 | 0.050 |
Why?
|
| Cyclin D3 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Elephantiasis, Filarial | 1 | 1999 | 1 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 51 | 0.040 |
Why?
|
| Chromatography | 1 | 1999 | 16 | 0.040 |
Why?
|
| Rural Health | 1 | 1999 | 53 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 388 | 0.040 |
Why?
|
| Urban Health | 1 | 1999 | 95 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 308 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 135 | 0.040 |
Why?
|
| Buffaloes | 1 | 1998 | 3 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2017 | 2 | 0.040 |
Why?
|
| Cross Reactions | 1 | 1998 | 83 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2016 | 77 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 114 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 146 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 275 | 0.030 |
Why?
|
| Age Factors | 1 | 1999 | 1033 | 0.030 |
Why?
|
| Sex Factors | 1 | 1999 | 898 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 325 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 156 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 39 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 22 | 0.030 |
Why?
|
| Nepal | 1 | 2013 | 15 | 0.030 |
Why?
|
| Multigene Family | 1 | 2013 | 106 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 677 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 91 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2013 | 81 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 623 | 0.030 |
Why?
|
| Mortality | 1 | 2013 | 145 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 534 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 61 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2007 | 9 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 78 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 113 | 0.020 |
Why?
|
| Perylene | 1 | 2006 | 8 | 0.020 |
Why?
|
| Telomerase | 1 | 2006 | 44 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 191 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 190 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 172 | 0.020 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2005 | 31 | 0.020 |
Why?
|
| Ligands | 1 | 2006 | 349 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3562 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 239 | 0.010 |
Why?
|